Posted by Michael Wonder on 18 Jul 2025
Pierre Fabre announces transfer of investigational new drug application for tabelecleucel from Atara Biotherapeutics
15 July 2025 - Pierre Fabre Laboratories is now responsible for all global clinical trial activities for the tabelecleucel clinical program.
Pierre Fabre Pharmaceuticals today announced the transfer of the Investigational New Drug Application for tabelecleucel from its partner, Atara Biotherapeutics.
